Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy

In the last 25 years, intravenous immunoglobulin (IVIg) has had a major impact in the successful treatment of previously untreatable or poorly controlled autoimmune neurological disorders. Derived from thousands of healthy donors, IVIg contains IgG1 isotypes of idiotypic antibodies that have the pot...

Descripción completa

Detalles Bibliográficos
Autor principal: Dalakas, Marinos C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585501/
https://www.ncbi.nlm.nih.gov/pubmed/34766257
http://dx.doi.org/10.1007/s13311-021-01108-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585501/
https://www.ncbi.nlm.nih.gov/pubmed/34766257
http://dx.doi.org/10.1007/s13311-021-01108-4

Ejemplares similares